Total Payments
$402,623
2024 Payments
$39,888
Companies
18
Transactions
215
Medicare Patients
240
Medicare Billing
$21,803
Payment Breakdown by Category
Consulting$241,801 (60.1%)
Travel$86,530 (21.5%)
Other$54,973 (13.7%)
Research$16,115 (4.0%)
Food & Beverage$3,205 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $241,801 | 78 | 60.1% |
| Travel and Lodging | $86,530 | 56 | 21.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $43,779 | 10 | 10.9% |
| Unspecified | $16,115 | 3 | 4.0% |
| Compensation for serving as faculty or as a speaker for a medical education program | $7,434 | 4 | 1.8% |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $3,759 | 1 | 0.9% |
| Food and Beverage | $3,205 | 63 | 0.8% |
Payments by Type
General
$386,508
212 transactions
Research
$16,115
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ipsen Innovation | $161,708 | 58 | $0 (2024) |
| Allergan, Inc. | $92,564 | 61 | $0 (2021) |
| Merz North America, Inc. | $27,182 | 10 | $0 (2018) |
| Ipsen Pharma SAS | $22,118 | 7 | $0 (2023) |
| Ipsen Biopharmaceuticals, Inc | $20,001 | 18 | $0 (2024) |
| Ossur Americas., Inc | $16,115 | 3 | $0 (2020) |
| Ipsen Biopharm Limited | $13,794 | 6 | $0 (2024) |
| Merz Pharmaceuticals GmbH | $13,287 | 8 | $0 (2017) |
| ABBVIE INC. | $12,776 | 19 | $0 (2024) |
| Shionogi Inc | $9,950 | 10 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $39,888 | 22 | Ipsen Innovation ($21,419) |
| 2023 | $18,513 | 11 | Ipsen Pharma SAS ($9,163) |
| 2022 | $49,391 | 27 | Ipsen Innovation ($34,628) |
| 2021 | $25,147 | 10 | Ipsen Biopharmaceuticals, Inc ($7,300) |
| 2020 | $47,087 | 34 | Allergan, Inc. ($21,542) |
| 2019 | $115,612 | 47 | Ipsen Innovation ($63,369) |
| 2018 | $55,740 | 31 | Merz North America, Inc. ($27,147) |
| 2017 | $51,245 | 33 | Ipsen Innovation ($19,717) |
All Payment Transactions
215 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| 11/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $39.84 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: DIABETES | ||||||
| 10/30/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Travel and Lodging | Cash or cash equivalent | $163.00 | General |
| Category: Pain Management | ||||||
| 10/30/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | Cash or cash equivalent | $107.00 | General |
| Category: Pain Management | ||||||
| 10/30/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | Cash or cash equivalent | $33.00 | General |
| Category: Pain Management | ||||||
| 07/31/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $10.36 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/13/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $40.96 | General |
| Category: Pain Management | ||||||
| 07/12/2024 | Ipsen Innovation | Dysport (Drug) | Consulting Fee | Cash or cash equivalent | $12,101.95 | General |
| Category: Neurology | ||||||
| 07/12/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Travel and Lodging | In-kind items and services | $381.03 | General |
| Category: Pain Management | ||||||
| 07/12/2024 | Ipsen Innovation | Dysport (Drug) | Travel and Lodging | In-kind items and services | $108.28 | General |
| Category: Neurology | ||||||
| 06/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/26/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $33.16 | General |
| Category: Neurology | ||||||
| 03/21/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| 03/06/2024 | Ipsen Biopharm Limited | — | Consulting Fee | Cash or cash equivalent | $2,130.00 | General |
| 02/23/2024 | Ipsen Bioscience Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,665.05 | General |
| 02/16/2024 | Ipsen Biopharm Limited | Dysport (Drug) | Consulting Fee | Cash or cash equivalent | $6,570.00 | General |
| Category: Neurology | ||||||
| 02/16/2024 | Ipsen Biopharm Limited | Dysport (Drug) | Travel and Lodging | In-kind items and services | $83.55 | General |
| Category: Neurology | ||||||
| 02/16/2024 | Ipsen Biopharm Limited | Dysport (Drug) | Food and Beverage | In-kind items and services | $10.50 | General |
| Category: Neurology | ||||||
| 01/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $36.36 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 01/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 01/17/2024 | Ipsen Innovation | Dysport (Drug) | Travel and Lodging | In-kind items and services | $9,208.45 | General |
| Category: Neurology | ||||||
| 11/17/2023 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Neurology | ||||||
| 11/02/2023 | Microtransponder, Inc. | — | Food and Beverage | Cash or cash equivalent | $143.12 | General |
| 10/06/2023 | Ipsen Pharma SAS | Dysport (Drug) | Consulting Fee | Cash or cash equivalent | $9,000.00 | General |
| Category: Neurology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| APO | Ossur Americas., Inc | $16,115 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 47 | 58 | $16,660 | $5,402 |
| 2022 | 3 | 56 | 61 | $13,693 | $5,252 |
| 2021 | 2 | 54 | 58 | $9,943 | $4,733 |
| 2020 | 4 | 83 | 126 | $23,639 | $6,416 |
Total Patients
240
Total Services
303
Medicare Billing
$21,803
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 30 | 41 | $9,435 | $2,991 | 31.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 17 | 17 | $7,225 | $2,411 | 33.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 15 | 15 | $6,375 | $2,186 | 34.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 23 | 26 | $4,758 | $2,070 | 43.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 18 | 20 | $2,560 | $995.24 | 38.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 20 | 21 | $3,923 | $2,248 | 57.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 18 | 20 | $3,740 | $1,709 | 45.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 16 | 17 | $2,280 | $776.14 | 34.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 44 | 63 | $8,064 | $2,493 | 30.9% |
| 64642 | Injection of chemical for destruction of nerve muscles on arm or leg, 1-4 muscles | Facility | 2020 | 12 | 24 | $9,696 | $2,134 | 22.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 16 | 16 | $4,384 | $1,422 | 32.4% |
| 95873 | Electrical stimulation for guidance with injection of chemical for destruction of muscles | Facility | 2020 | 11 | 23 | $1,495 | $366.45 | 24.5% |
About Dr. Alberto Esquenazi, MD
Dr. Alberto Esquenazi, MD is a Physical Medicine & Rehabilitation healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801843859.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alberto Esquenazi, MD has received a total of $402,623 in payments from pharmaceutical and medical device companies, with $39,888 received in 2024. These payments were reported across 215 transactions from 18 companies. The most common payment nature is "Consulting Fee" ($241,801).
As a Medicare-enrolled provider, Esquenazi has provided services to 240 Medicare beneficiaries, totaling 303 services with total Medicare billing of $21,803. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Philadelphia, PA
- Active Since 05/27/2006
- Last Updated 03/02/2011
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1801843859
Products in Payments
- DYSPORT (Drug) $107,933
- Dysport (Drug) $57,311
- BOTOX (Biological) $41,486
- XEOMIN (Biological) $27,147
- Dysport 300 U-1 (Drug) $22,380
- Xeomin (Biological) $13,321
- BOTOX (Drug) $12,201
- BOTOX THERAPEUTIC (Biological) $11,111
- LYVISPAH (Drug) $5,400
- BOTOX COSMETIC (Biological) $3,736
- OZURDEX (Drug) $747.90
- Iovera (Device) $421.99
- Exparel (Drug) $303.00
- BOTOX NEURO REHAB (Drug) $74.54
- Kerendia (Drug) $49.76
- BOTOX - NEUROLOGY (Drug) $31.00
- JARDIANCE (Drug) $25.71
- INJECTAFER (Drug) $22.52
- Velphoro (Drug) $20.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Philadelphia
Nicole Spare, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $125,419
Physical Medicine & Rehabilitation $125,419
Kimberly Heckert, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $119,125
Physical Medicine & Rehabilitation $119,125
Dr. Cameron Olezene, Md, MD
Physical Medicine & Rehabilitation — Payments: $50,892
Physical Medicine & Rehabilitation $50,892
Parisa Sedaghat, Md, MD
Physical Medicine & Rehabilitation — Payments: $15,206
Physical Medicine & Rehabilitation $15,206
Dr. Elaine Hatch, Md, MD
Physical Medicine & Rehabilitation — Payments: $15,091
Physical Medicine & Rehabilitation $15,091
Dr. Marisa Moreta, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $13,301
Physical Medicine & Rehabilitation $13,301